今日盘中，港股上市公司药明生物（02269）股价大涨6.10%，引发市场广泛关注。这一显著涨幅很可能与近期持续的南向资金流入有关。
据最新数据显示，3月31日南向资金增持药明生物730.71万股，这已经是连续第三个交易日出现增持。截至3月31日收盘，港股通持有药明生物117311.15万股，占流通股的28.56%，显示出投资者对该公司的持续看好。
值得注意的是，药明生物近期表现强劲。数据显示，该股票在过去5个交易日累计上涨2.66%，期间港股通累计增持1289.94万股。而在近20个交易日内，涨幅更是达到了20.76%，同期港股通累计增持1982.89万股。这种持续的资金流入和股价上涨趋势，反映出市场对药明生物未来发展前景的积极预期，也为今日的大幅上涨奠定了基础。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.